Cannabidiol in Sickle Cell Disease

Clinical trial NCT06930703 · RECRUITING

Trial details

NCT number: NCT06930703
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2025-04-03
Primary completion: 2027-02-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.